Coronavirus: EU Calls For Unity, as It Seeks To Avoid A vaccine War

European countries must not turn on each other amid growing tensions over Covid vaccine supplies, the president of the EU Parliament has said.

The call for unity comes as EU leaders hold virtual talks to discuss supplies and improving distribution across the bloc's 27 member states.

Some countries have complained that doses have not been distributed fairly.

The meeting on Thursday will also see EU leaders decide whether to approve proposals to toughen export controls.

Such controls could affect supply to the UK, where Prime Minister Boris Johnson has warned against imposing "blockades".

European Commission head Ursula von der Leyen tweeted that the summit would "ensure that Europeans get their fair share of vaccines".

Some EU states, led by Austria, are calling for a revision in the bloc's distribution method after failing to obtain enough doses earlier this year.

"There is no sense in us turning on each other, just as there is no sense in thinking that others are doing much better," European Parliament President David-Maria Sassoli said at a press conference on Thursday.

"The more unity we show, the more trust we will inspire," he added. "Salvation lies in working together."

Vaccine rollouts in EU states have started sluggishly, and the bloc has blamed pharmaceutical companies - primarily AstraZeneca - for not delivering its promised doses. The company denies that it is failing to honour its contract.

European Council President Charles Michel is hosting the video conference with EU leaders, as tensions rise over how to distribute doses among member states.

Austria's Chancellor Sebastian Kurz is heading a campaign with five Eastern European nations to address what they say has been an uneven distribution of vaccines.

"If no solution is found here it could cause damage to the European Union the likes of which we have not seen in a long time," Mr Kurz said ahead of the summit.

The EU is also divided over plans to introduce new export controls on vaccines in an effort to boost its own supply.

Some member states fear the controls would disrupt global supply chains and damage already strained relations with the UK after Brexit, the BBC's Katya Adler says.

The proposals are most likely to affect vaccine-exporting countries that have higher vaccination rates than the EU, such as the UK and US.

When considering whether to limit exports, the EU would consider the state of the pandemic in that country, its vaccination rate, and whether the country is itself exporting vaccines.

There would, however, be no outright export bans.

A site in Belgium produces the Oxford-AstraZeneca vaccine, and another in the Netherlands is expected to increase supplies of the jab in the EU. Brussels has said that of the more than 40 million doses exported from the EU over the past two months, a quarter were sent to the UK.

Ahead of Thursday's summit, the former president of the European Commission Jean Claude Juncker urged the bloc to avoid a "stupid vaccine war" with the UK.

"This cannot be dealt with in a war atmosphere," he told the BBC's Hardtalk programme. "We are not in war, and we are not enemies."

He added that threats of export bans could cause "major reputational damage" to the EU.

Meanwhile, German Chancellor Angela Merkel called for the EU to boost its capacity for vaccine production.

"We can see clearly that British facilities are producing for Great Britain," she said. "The United States isn't exporting, and therefore we are dependent upon what can be produced in Europe."

Mrs Merkel also defended the EU's decision to procure coronavirus vaccines jointly, before warning that the impact of the pandemic could go "far beyond this year".

In another development, Denmark suspended its use of the Oxford-AstraZeneca jab by a further three weeks and said it was still looking at a possible link to blood clots.

Europe's medicines regulator declared that the jab was "safe and effective" last week, and is convening a group of experts to explore the issue further on Monday. There is no evidence that the jab is connected to the reports of clots.